The emerging field of peptide financial transactions presents unique hurdles for merchants, frequently categorized as sub-optimal due to fears regarding dishonest activity, reversals, and the complexity of the associated product marketing. Obtaining payment processing solutions can be complicated for these companies, often requiring specialized con